We are live on ! Find out more
MREO

Mereo BioPharma
MREO

61 hedge funds and large institutions have $46.2M invested in Mereo BioPharma in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

7% more call options, than puts

Call options by funds: $93K | Put options by funds: $87K

1.03% less ownership

Funds ownership: 10.88% → 9.85% (-1%)

3% less funds holding

Funds holding: 63 → 61 (-2)

7% less capital invested

Capital invested by funds: $49.4M → $46.2M (-$3.27M)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Holders
61
Holders Change
-2
Holders Change %
-3.17%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
15
Reduced
14
Closed
8
Calls
$93K
Puts
$87K
Net Calls
+$6K
Net Calls Change
+$55K

Top Buyers

Rank Fund Capital Flow
1
MAM
Monaco Asset Management
Monaco
+$1.53M
2
Goldman Sachs
Goldman Sachs
New York
+$1.3M
3
E
Ergoteles
New York
+$109K
4
JP Morgan Chase
JP Morgan Chase
New York
+$109K
5
Barclays
Barclays
United Kingdom
+$104K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.46M
2
CC
Clearline Capital
New York
-$1.56M
3
BlackRock
BlackRock
New York
-$565K
4
Morgan Stanley
Morgan Stanley
New York
-$99.9K
5
CHAM
Clear Harbor Asset Management
Connecticut
-$50.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFSG
51
Newbridge Financial Services Group
Florida
$3K – – –
Citigroup
52
Citigroup
New York
$1.16K -$14.3K -17,368 -92%
AF
53
Allworth Financial
California
$1.13K +$1.23K +1,500 New
SIA
54
Sit Investment Associates
Minnesota
$1K – – –
BNP Paribas Financial Markets
55
BNP Paribas Financial Markets
France
$421 +$20 +24 +4%
NECFA
56
New England Capital Financial Advisors
Connecticut
$291 +$246 +300 New
Wells Fargo
57
Wells Fargo
California
$173 -$411 -500 -68%
PMFA
58
Plante Moran Financial Advisors
Michigan
$36 – – –
US Bancorp
59
US Bancorp
Minnesota
$10 – – –
Point72 Asset Management
60
Point72 Asset Management
Connecticut
– -$8.46M -9,829,354 Closed
BlackRock
61
BlackRock
New York
– -$565K -657,182 Closed
MA
62
MYDA Advisors
New York
– -$19K -21,502 Closed
OIA
63
OneDigital Investment Advisors
Kansas
– -$17K -19,362 Closed
Balyasny Asset Management
64
Balyasny Asset Management
Illinois
– -$17K -19,211 Closed
TSS
65
Two Sigma Securities
New York
– -$9K -10,043 Closed
CUAMC
66
China Universal Asset Management Company
China
– -$1K -1,095 Closed
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
– -$177 -215 -88%
1 2
3

MREO Hedge Fund Activity: Q4 2022 in Review

61 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Mereo BioPharma (MREO) for Q4 2022, worth a combined $46.2M — down 6.6% from $49.4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of MREO and 6 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 15 added.

The largest buyer was Monaco Asset Management, adding an estimated $1.53M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $8.46M sold.

  • 61 institutional investors held Mereo BioPharma (MREO) as of Q4 2022, down from 63 in Q3 2022.
  • Funds reported $46.2M of Mereo BioPharma stock for Q4 2022, down 6.6% quarter-over-quarter.
  • 6 funds opened new Mereo BioPharma positions in Q4 2022 and 8 closed out, a net change of -2 holders.
  • The largest Mereo BioPharma buyer in Q4 2022 was Monaco Asset Management, an estimated $1.53M added.
  • The largest Mereo BioPharma seller in Q4 2022 was Point72 Asset Management, an estimated $8.46M sold.

Based on aggregated 13F filings for Q4 2022.